Skip to content

Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors

The Effects of Cross Training on Fatigue and Pain Levels in Breast Cancer Survivors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00336089
Enrollment
54
Registered
2006-06-12
Start date
2006-01-31
Completion date
Unknown
Last updated
2013-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Cancer Survivor, Fatigue, Pain

Keywords

fatigue, pain, cancer survivor, breast cancer in situ, inflammatory breast cancer, stage IA breast cancer, stage IB breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer, stage IV breast cancer, recurrent breast cancer

Brief summary

RATIONALE: An exercise program or health education program may help relieve fatigue and pain and improve the quality of life in women who are breast cancer survivors. It is not yet known whether an exercise program is more effective than a health education program or no program in reducing fatigue and pain in women who are breast cancer survivors. PURPOSE: This randomized clinical trial is studying an exercise program to see how well it works in reducing fatigue and pain compared to a health education program or no program in women who are breast cancer survivors.

Detailed description

OBJECTIVES: * Determine whether a moderate-intensity exercise program comprising cardiorespiratory and resistance training of the legs, back, abdominal, trunk, and arm musculature vs a control group attenuates fatigue and pain in breast cancer survivors. * Determine whether this exercise program will significantly improve the quality of life of these patients. * Determine whether this exercise program can significantly reduce the number of days of absenteeism from work in these patients. * Determine whether this exercise program can significantly attenuate mood disturbances in these patients. OUTLINE: This is a randomized, controlled, pilot study. Patients are randomized to 1 of 2 treatment arms. * Arm I (exercise program): Patients participate in an exercise program comprising cardiorespiratory (walking on a treadmill) and resistance training for 1 hour, 3 times weekly for 12 weeks. * Arm II (control): Patients undergo no intervention. In both arms, patients complete questionnaires regarding general health, mood, work attendance, and physical activity before the start of study treatment and then every 3 weeks for 12 weeks. Patients also complete a 7-day physical activity diary and sleep diary every 3 weeks. PROJECTED ACCRUAL: A total of 54 patients will be accrued for this study.

Interventions

PROCEDUREpain therapy
BEHAVIORALexercise intervention
OTHEReducational intervention
PROCEDUREquality-of-life assessment
PROCEDUREfatigue assessment and management
PROCEDUREmanagement of therapy complications

Sponsors

Clayton State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Breast cancer survivor * Received adjuvant chemotherapy or radiotherapy for breast cancer only * Must have completed treatment 2-6 months ago * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Female * Menopausal status not specified * Hemoglobin ≥ 11 g/dL * Able to read English * No high-risk for cardiovascular problems during exercise, including any of the following: * Unstable heart disease * Unstable angina * Chronic respiratory disease * Dizziness * Uncontrolled hypertension * No severe respiratory disease requiring oxygen therapy * No history of anorexia (body mass index \[BMI\] \< 18.5) or severe obesity (BMI \> 35) * No history of multiple cancers * No shortness of breath or hypotension * No sudden swelling of the ankles, hands or face * No palpitations or arrhythmias * No persistent and intolerable pain * No major acute illness (e.g., fever or respiratory infection) PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026